Botulinum Toxin in the Treatment of Gingival Smile
Launched by UNIVERSIDADE IBIRAPUERA · Jan 20, 2019
Trial Information
Current as of June 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients of both genders exhibiting gingival exposure greater than or equal to 3 mm above the central incisor during smile
- • 2. Patients with good general health and good oral hygiene.
- Exclusion Criteria:
- • 1. Patients with Botulinum Toxin allergy or albumin, or who have previously performed botulinum toxin facial treatment previously.
- • 2. Patients with Amyotrophic Lateral Sclerosis, Neuropathy, Myasthenia Gravis or Lambert-Eaton Syndrome, women who are pregnant or planning to become pregnant, are breastfeeding women.
- • 3. Patients who are participating in other research involving other drugs.
- • 4. Patients who use drugs that interfere with neuromuscular transmission
About Universidade Ibirapuera
Universidade Ibirapuera is a distinguished academic institution committed to advancing healthcare and scientific research through innovative clinical trials. With a focus on enhancing patient outcomes and contributing to the medical community, the university fosters collaboration among researchers, clinicians, and industry partners. Its robust infrastructure and dedication to ethical research practices ensure that all clinical trials conducted under its auspices adhere to the highest standards of quality and integrity, ultimately aiming to translate scientific discoveries into effective therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, Sp, Brazil
Patients applied
Trial Officials
Aline B Costa, DDS
Study Chair
Ibirapuera University
Dinete Romansina, MSc
Study Chair
University of Sao Paulo
Juliana Ramalho, DDS
Study Chair
Ibirapuera University
Karen M Ramalho, PhD
Principal Investigator
Ibirapuera University
Susana Morimoto, PhD
Study Chair
Ibirapuera University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials